Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.50 (7.143%)
Open: 7.25
High: 7.25
Low: 7.25
Prev. Close: 7.25
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 Apr 2022 13:00

RNS Number : 2350J
Belluscura PLC
25 April 2022
 

 25 April 2022 

Belluscura plc

("BELL" or the "Company")

Result of AGM

Belluscura plc (AIM: BELL) announces that at the Annual General Meeting ("AGM") held earlier today all the resolutions put to the meeting were duly approved by shareholders: 

Resolution (*indicates special resolution)

Votes for

% of shares voted

Votes against

% of shares voted

Resolution 1: To receive and adopt the report of the directors and the financial statements for the period ended 31 December 2021.

32,658,693

99.9%

4,000

0.01%

Resolution 2: To re-elect Mr Adam Reynolds as a director of the Company.

32,658,693

99.9%

4,000

0.01%

Resolution 3. To re-elect Mr Ric Piper as a director of the Company.

32,658,693

99.9%

4,000

0.01%

Resolution 4: To re-appoint Jeffreys Henry Audit Limited as auditors.

 

32,658,693

99.9%

4,000

0.01%

Resolution 5: To authorise the directors to determine the remuneration of the auditors.

32,658,693

99.9%

4,000

0.01%

Resolution 6: To grant the directors authority to allot shares pursuant to Section 551 of the Companies Act 2006.

32,658,693

99.9%

4,000

0.01%

Resolution 7*: To dis-apply pre-emption rights pursuant to Section 570 of the Companies Act 2006.

32,658,693

99.9%

4,000

0.01%

Resolution 8*: To authorise the directors to make market purchases.

32,662,693

100.0%

0

0.00%

*Special resolutions

For further information, please visit www.belluscura.com or contact:  

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via Walbrook PR

Anthony Dyer, Chief Financial Officer

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com

Paul McManus / Sam Allen

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDZGZDMKKGZZM
Date   Source Headline
13th Dec 20227:00 amRNSFirst international distribution agreement
14th Nov 20224:40 pmRNSSecond Price Monitoring Extn
14th Nov 20224:35 pmRNSPrice Monitoring Extension
14th Nov 20222:06 pmRNSSecond Price Monitoring Extn
14th Nov 20222:00 pmRNSPrice Monitoring Extension
14th Nov 202211:05 amRNSSecond Price Monitoring Extn
14th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSBelluscura receives certification to ISO standard
31st Oct 20225:46 pmRNSHolding(s) in Company
31st Oct 20225:41 pmRNSDirector/PDMR Shareholding
31st Oct 20225:38 pmRNSDirector/PDMR Shareholding
24th Oct 20227:00 amRNSBelluscura wins two HME Business Awards
23rd Sep 202211:45 amRNSHolding(s) in Company
20th Sep 20227:01 amRNSHalf-year Report
20th Sep 20227:00 amRNSBelluscura signs agreement with US distributor
6th Sep 20227:00 amRNSNotice of Results
18th Aug 20221:25 pmRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20222:26 pmRNSAgreement with VGM, largest MSO in US-replacement
2nd Aug 202212:53 pmRNSAgreement with VGM, largest DSO in US-replacement
2nd Aug 20227:00 amRNSSupply Agreement with VGA, largest MSO in the US
15th Jul 20227:00 amRNSWarrant Exercise
14th Jul 20227:00 amRNSExercise of Warrants
30th Jun 20227:00 amRNSDirect to Consumer Sales and Distribution Plan
27th Jun 20227:00 amRNSLaunch of Next Gen X-PLOR Oxygen Concentrator
25th May 20221:19 pmRNSTR-1: Notification of major holdings
24th May 20225:27 pmRNSTR-1: Notification of major holdings
19th May 20227:00 amRNSBelluscura Expands its Patent Portfolio
17th May 202212:00 pmRNSApplications Announcement
13th May 202211:00 amRNSResult of Placing
12th May 20225:01 pmRNSProposed placing to raise £5.0m
25th Apr 20221:00 pmRNSResult of AGM
21st Apr 20227:00 amRNSSenior Management Appointment
7th Apr 20227:00 amRNSDAPA Contract
5th Apr 20226:31 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSSenior Management Appointment
1st Apr 20227:00 amRNSNotice of AGM and Annual Report 2021
30th Mar 20227:00 amRNSManufacturing Agreement
22nd Feb 20227:00 amRNSFinal Results
27th Jan 202211:06 amRNSSecond Price Monitoring Extn
27th Jan 202211:00 amRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSTrading Update and Notice of Preliminary Results
20th Jan 20222:32 pmRNSExercise of Warrants and Total Voting Rights
13th Jan 202211:05 amRNSSecond Price Monitoring Extn
13th Jan 202211:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSExercise of Warrants and Total Voting Rights
29th Nov 20217:01 amRNSReimbursement approvals
29th Nov 20217:00 amRNSExercise of Warrants and Total Voting Rights
4th Nov 20217:00 amRNSTrading update
1st Nov 20217:00 amRNSThe Pulse: Healthcare Innovation Breakfast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.